Argan director sells 300 shares at $705

ARGAN INC director Karen Sweeney reported an open-market sale of company stock.

(Moderate)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

ARGAN INC director Karen Sweeney reported an open-market sale of company stock. On June 17, 2026, she sold 300 shares of Argan common stock at a price of $705 per share. After this transaction, she directly holds 1,548 shares of Argan common stock.

Insider Trade Summary

Net Seller: 300 shares

Net Sell 1 txn

Insider Sweeney Karen

Role Director

Sold 300 shs ($212K)

Type	Security	Shares	Price	Value
Sale	Common Stock	300	$705.00	$212K

Holdings After Transaction: Common Stock — 1,548 shares (Direct)

Footnotes (1)

F1. On June 17, 2026, the Reporting Person sold 300 shares of the Issuer's common stock on the open market at a price of $705 per share.

Key Figures

Shares sold: 300 shares Sale price: $705 per share Shares held after sale: 1,548 shares +1 more

4 metrics

Shares sold 300 shares Open-market sale of Argan common stock on June 17, 2026

Sale price $705 per share Price for 300 Argan common shares sold on June 17, 2026

Shares held after sale 1,548 shares Direct holdings of Argan common stock following the transaction

Net shares sold 300 shares Net change in Argan share position from this reported transaction

Key Terms

open-market sale, Common Stock, Form 4

3 terms

open-market sale financial

"sold 300 shares of the Issuer's common stock on the open market at a price of $705 per share"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"the Issuer's common stock on the open market at a price of $705 per share"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"according to the Form 4 insider filing for June 17, 2026"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ARGAN INC (AGX) director Karen Sweeney report?

Director Karen Sweeney reported an open-market sale of ARGAN INC common stock. She sold 300 shares in a single transaction and now directly holds 1,548 shares, according to the Form 4 insider filing for June 17, 2026.

How many ARGAN INC (AGX) shares did Karen Sweeney sell and at what price?

Karen Sweeney sold 300 shares of ARGAN INC common stock at $705 per share. This open-market transaction was reported in a Form 4 filing and reflects a partial sale of her existing direct holdings in the company.

What are Karen Sweeney’s ARGAN INC (AGX) holdings after this Form 4 sale?

After selling 300 shares, Karen Sweeney directly holds 1,548 ARGAN INC common shares. This post-transaction balance is disclosed in the Form 4 and represents her remaining direct ownership following the June 17, 2026 open-market sale.

Was the ARGAN INC (AGX) transaction by Karen Sweeney an open-market sale?

Yes. The Form 4 describes the transaction as an open-market sale of ARGAN INC common stock. She sold 300 shares at $705 per share, and this sale reduced her directly held position to 1,548 shares after the transaction.

When did ARGAN INC (AGX) director Karen Sweeney execute her reported stock sale?

Karen Sweeney executed the reported sale on June 17, 2026. On that date, she sold 300 shares of ARGAN INC common stock in an open-market transaction at a price of $705 per share, as detailed in the Form 4 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/17/2026 - 04:30 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sweeney Karen

(Last)

(First)

(Middle)

22550 CALVERTON ROAD

(Street)

SHAKER HEIGHTS

OHIO

44122

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/17/2026		S		300⁽¹⁾	D	$705	1,548	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On June 17, 2026, the Reporting Person sold 300 shares of the Issuer's common stock on the open market at a price of $705 per share.

	/s/ Karen A. Sweeney	06/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR